-
Mashup Score: 1Why I . . . am involved in musical theatre - 9 month(s) ago
Consultant oncologist Alison Birtle talks to Helen Jones about her love of performing and how it is helping her recovery from serious complications of covid “I had already decided at the age of four that I wanted to be a doctor, but music and performing are a big part of my life,” says consultant oncologist Alison Birtle. While at medical school in London she performed in Grease , Cabaret , and…
Source: The BMJCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial - 9 month(s) ago
Key Points. Non-Restrictive diet is non-inferior to traditional Protective diet during neutropenia after HSCT.In multivariable analysis, multiple myeloma diagno
Source: American Society of HematologyCategories: Latest Headlines, Oncologists1Tweet-
Great for patients! Non-Restrictive diet is non-inferior to traditional low microbial protective diet during neutropenia after autologous transplant - data from a multicenter randomized trial https://t.co/x0SGRKhaxc @BloodAdvances
-
-
Mashup Score: 0Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium - PubMed - 10 month(s) ago
In the standard-of-care setting, the efficacy and toxicity of brexu-cel were consistent with those reported in the ZUMA-2 trial. Tumor-intrinsic features of MCL, and possibly recent bendamustine exposure, may be associated with inferior efficacy outcomes.
Source: PubMedCategories: Latest Headlines, Oncologists1Tweet-
SCI members Matthew Frank, David Miklos & others demonstrate encouraging safety and efficacy results of brexu-cel in standard-of-care practice, supporting continuous and expanded use of it for R/R #MantleCellLymphoma in routine practice. https://t.co/tjyRSWTY8z #celltherapy https://t.co/HMpBTwp0Nj
-
-
Mashup Score: 0
22nd Annual International Congress on the Future of Breast Cancer® East.
Source: event.gotoper.comCategories: Latest Headlines, Oncologists1Tweet-
Join me and thought leaders in NYC from July 14-15 for the 22nd Annual International Congress on the Future of Breast Cancer® East. Register now by visiting: https://t.co/uREftlJN0t. Registration is free using Jhaveri as your code!
-
-
Mashup Score: 3Stanford Cancer Institute Breakthroughs in Cancer: Charles Sawyers, MD - 10 month(s) ago
Topic: Prostate Cancer Initiation and PlasticityMemorial Sloan Kettering physician-scientist Charles Sawyers, MD, specializes in new drug development for leu…
Source: YouTubeCategories: Latest Headlines, Oncologists1Tweet-
I had the pleasure of hosting Charles Sawyers from @MSKCancerCenter as our distinguished guest at our monthly Breakthroughs in Cancer seminar. Watch: https://t.co/EiZfCxZSL1. #prostatecancer Save the date for our 9/12 seminar with Ursula Matulonis of @DanaFarber #OvarianCancer
-
-
Mashup Score: 1
In this small, single-group study involving patients with papillary craniopharyngiomas, 15 of 16 patients had a partial response or better to the BRAF-MEK inhibitor combination vemurafenib-cobimetinib. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT03224767.).
Source: PubMedCategories: Latest Headlines, Oncologists1Tweet-
#PrecisionMedicine for a rare brain cancer: Papillary craniopharyngiomas. ➡️>90% have BRAF V600E ➡️94% ORR to anti-BRAF-MEK therapy (n=16 pts) Impressive! @NEJM @OncoAlert BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas https://t.co/5kJbM6tO8p
-
-
Mashup Score: 0Join our Cloud HD Video Meeting - 10 month(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…
Source: Zoom VideoCategories: Latest Headlines, Oncologists1Tweet-
➡️ Happening now! @VUMC_Medicine grand rounds: @CathyEngMD presents “The Enigma of Early Onset #Colorectal #Cancer”. In person + livestream: https://t.co/uSIlr3F76w Dr. Eng is a leading expert on this important public health topic! @OncoAlert @VUMC_Cancer @VUMChealth https://t.co/zP0xnFzwlU
-
-
Mashup Score: 7THE ONCOALERT NETWORK - 10 month(s) ago
Welcome to OncoAlert
Source: THE ONCOALERT NETWORKCategories: Latest Headlines, Oncologists1Tweet-
RT @OncoAlert: The @oncoAlert 🚨Newsletter OUT TOMORROW July 13th, 2023 REGISTER📨to get it https://t.co/yzt83gqQkF Discussing: Update…
-
-
Mashup Score: 0Nomination Committee Elections 2023 - 10 month(s) ago
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
Source: www.esmo.orgCategories: Latest Headlines, Oncologists1Tweet-
If you are an @myESMO #member you have now the chance to choose #ESMO Nomination #Committee The Electronic Ballot Vote is Now Open 📥 You can find out more about the candidates & view their documentation here → https://t.co/dnIvoBsuO9
-
-
Mashup Score: 1HOME - 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® - 10 month(s) ago
19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®.
Source: event.gotoper.comCategories: Latest Headlines, Oncologists1Tweet-
RT @OmidHamidMD: https://t.co/anqdh0QqtR CODE: HAMID for free reg @TXHealthSurgery @TexasHealthy @texashealth @CHWhiteRock @DallasEMed @Chi…
-
RT @pash22: Why I . . . am involved in musical theatre https://t.co/q5iuh665Ay @AlisonBirtle talks to @bmj_latest 's #HelenJones